Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01225406
Recruitment Status : Completed
First Posted : October 21, 2010
Last Update Posted : January 26, 2017
Ministry of Education, Thailand
National Health Security Office, Thailand
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration